Neuphoria Therapeutics Statistics
NASDAQ: NEUPHealth CareBiotechnology: Pharmaceutical PreparationsUSD
3.37-0.05 (-1.46%)
Market open · Delayed 15 min · as of Oct 8, 12:45 PM ET
Neuphoria Therapeutics by the numbers
Neuphoria Therapeutics has a market capitalization of $18.2 million based on 5.41M shares outstanding. With trailing EPS of $-3.06, Neuphoria Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 10.4% below its 50-day average and 20.0% below its 200-day average.
Average daily trading volume is 162.11K shares, or about $546,311 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NEUP valuation vs. peer median
| Metric | NEUP | Peer median | Difference |
|---|---|---|---|
| Market cap | $18.24M | $16.97M | +7% |
| Avg. volume | 162.11K | 63.45K | +156% |
Peer median across 8 companies: AKTX, QNTM, PTN, MRKR, COCP, NCEL, LPCN, RADX.
Valuation
- Market cap
- $18.24M
- EPS (TTM)
- $-3.06
- Shares outstanding
- 5.41M
Price and trading
- Previous close
- 3.42
- Open
- 3.40
- Day range
- 3.37 – 3.42
- 52-week range
- 3.19 – 19.21
- 52-week change
- -81.78%
- Beta
- —
- Volume
- 9.62K
- Average volume
- 162.11K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Mar 13, 2025
Additional statistics
- Market Cap
- 18.24M
- Forward Pe
- -1.37
- Eps
- -3.06
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 19.21
- Week52 Low
- 3.19
- Avg Volume
- 162.11K
- Shares Outstanding
- 5.41M
- Ma50
- 3.76
- Ma200
- 4.21
- Earnings Date
- Mar 13, 2025
- Pct From52w High
- -82.46%
- Pct From52w Low
- 5.64%